Literature DB >> 21304541

Kidney cancer in 2010: drugs, surgery and survival in RCC.

Karim Bensalah1, Jean-Jacques Patard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21304541     DOI： 10.1038/nrurol.2010.228

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  Tumor size and nephron-sparing surgery: does it still matter?

Authors:  Karim Bensalah; Maxime Crépel; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

2.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

Authors:  Christopher J Weight; Benjamin T Larson; Amr F Fergany; Tianming Gao; Brian R Lane; Steven C Campbell; Jihad H Kaouk; Eric A Klein; Andrew C Novick
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

Review 3.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

4.  Every minute counts when the renal hilum is clamped during partial nephrectomy.

Authors:  R Houston Thompson; Brian R Lane; Christine M Lohse; Bradley C Leibovich; Amr Fergany; Igor Frank; Inderbir S Gill; Michael L Blute; Steven C Campbell
Journal:  Eur Urol       Date:  2010-06-09       Impact factor: 20.096

5.  Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.

Authors:  Alexander Kutikov; Brian L Egleston; Yu-Ning Wong; Robert G Uzzo
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

6.  Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

Authors:  Karim Bensalah; Allan J Pantuck; Nathalie Rioux-Leclercq; Rodolphe Thuret; Francesco Montorsi; Pierre I Karakiewicz; Nicolas Mottet; Laurent Zini; Roberto Bertini; Laurent Salomon; Arnaud Villers; Michel Soulie; Laurent Bellec; Pascal Rischmann; Alexandre De la Taille; Raffi Avakian; Maxime Crepel; Jean-Marie Ferriere; Jean-Christophe Bernhard; Thierry Dujardin; Frédéric Pouliot; Jérôme Rigaud; Christian Pfister; Baptiste Albouy; Laurent Guy; Steven Joniau; Hendrik van Poppel; Thierry Lebret; Thibault Culty; Fabien Saint; Amnon Zisman; Orit Raz; Hervé Lang; Romain Spie; Andreas Wille; Jan Roigas; Alfredo Aguilera; Bastien Rambeaud; Luis Martinez Piñeiro; Ofer Nativ; Roy Farfara; François Richard; Morgan Roupret; Christian Doehn; Patrick J Bastian; Stefan C Muller; Jacques Tostain; Arie S Belldegrun; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2009-03-31       Impact factor: 20.096

7.  Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

Authors:  Ofer Yossepowitch; R Houston Thompson; Bradley C Leibovich; Scott E Eggener; Joseph A Pettus; Eugene D Kwon; Harry W Herr; Michael L Blute; Paul Russo
Journal:  J Urol       Date:  2008-06       Impact factor: 7.450

8.  Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.

Authors:  Cora N Sternberg; Ian D Davis; Jozef Mardiak; Cezary Szczylik; Eunsik Lee; John Wagstaff; Carlos H Barrios; Pamela Salman; Oleg A Gladkov; Alexander Kavina; Juan J Zarbá; Mei Chen; Lauren McCann; Lini Pandite; Debasish F Roychowdhury; Robert E Hawkins
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544
  8 in total
  2 in total

1.  CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Authors:  J Xie; Y Yuan; Z Liu; Y Xiao; X Zhang; C Qin; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

2.  IgG is involved in the migration and invasion of clear cell renal cell carcinoma.

Authors:  Zhengzuo Sheng; Yang Liu; Caipeng Qin; Zhenhua Liu; Yeqing Yuan; FengZhan Hu; Yiqing Du; Huaqi Yin; Xiaoyan Qiu; Tao Xu
Journal:  J Clin Pathol       Date:  2015-10-30       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.